tirzepatide rebound weight gain after stopping semaglutide or is real, but it’s not because the body is “damaged”—it reflects how the body adapts Long-Term Use of Obesity Management

Yes, regular site rotation between and within approved regions (abdomen, thigh, upper arm) is recommended to reduce injection site reactions and maintain consistent medication absorption

More on our GLP-1 Step Down program: To view or add a comment, sign in New paper alert: The Economic Impact of Diabetes This new study quantifies the incremental direct healthcare costs of diabetes with clear, decision-relevant estimates

Retatrutide is an investigational once-weekly injectable medicine being developed by Eli Lilly for the treatment of obesity and overweight

Strength 2 mg / 1.5 ml, 4 mg / 3 ml Pack Size 1s Dosage Form Injection (Vial) Categories Biological Therapeutic Class Anti-Diabetic

Differences in cohort, duration, and titration make a precise cross-trial advantage unreliable